Treatment of dermatological conditions
AssigneeMC2 Therapeutics Limited
InventorsTorkil Menne, Johan Selmer, Jesper Lange, Jon Bondebjerg, Michelle Georgiou
Life of this patent
Estimating the term…
Abstract
Provided is a pharmaceutical composition which comprises a nucleophilic compound capable of inhibiting carbamylation, for use in the treatment of a condition involving cutaneous or connective tissue damage. A method for treating a condition involving cutaneous or connective tissue damage in a patient, is also provided, said method comprising administering a said pharmaceutical composition to said patient.
Claims10
A pharmaceutical composition comprising a nucleophilic compound capable of inhibiting carbamylation, for use in the treatment of lichen sclerosus.
A method for treating lichen sclerosus in a patient, said method comprising administering a pharmaceutical composition comprising a nucleophilic compound capable of inhibiting carbamylation to a patient in need of such a treatment.
Dependencies are inferred from the claim text.